Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
<h4>Background and purpose</h4>Central adjudication of serious adverse events (SAEs) can be undertaken in clinical trials, especially for open-label studies where outcome assessment may be at risk of bias. This study explored the effect of central adjudication of SAEs on the safety results of the Ef...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Public Library of Science (PLoS)
2018-01-01
|
| Sraith: | PLoS ONE |
| Rochtain ar líne: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0208142&type=printable |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
